Targeting the Regulatory Site of ER Aminopeptidase 1 Leads to the Discovery of a Natural Product Modulator of Antigen Presentation.
Liddle, J., Hutchinson, J.P., Kitchen, S., Rowland, P., Neu, M., Cecconie, T., Holmes, D.S., Jones, E., Korczynska, J., Koumantou, D., Lea, J.D., Nickels, L., Pemberton, M., Phillipou, A., Schneck, J.L., Sheehan, H., Tinworth, C.P., Uings, I., Wojno-Picon, J., Young, R.J., Stratikos, E.(2020) J Med Chem 63: 3348-3358
- PubMed: 32109056 
- DOI: 10.1021/acs.jmedchem.9b02123
- Primary Citation of Related Structures:  
6T6R - PubMed Abstract: 
ER aminopeptidase 1 (ERAP1) is an intracellular enzyme that generates antigenic peptides and is an emerging target for cancer immunotherapy and the control of autoimmunity. ERAP1 inhibitors described previously target the active site and are limited in s ...